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Gene expression (GE) data capture valuable condition-specific information (“condition” can mean a biological process, dis-
ease stage, age, patient, etc.) However, GE analyses ignore physical interactions between gene products, i.e., proteins. Since
proteins function by interacting with each other, and since biological networks (BNs) capture these interactions, BN analyses
are promising. However, current BN data fail to capture condition-specific information. Recently, GE and BN data have been
integrated using network propagation (NP) to infer condition-specific BNs. However, existing NP-based studies result in a
static condition-specific network, even though cellular processes are dynamic. A dynamic process of our interest is aging. We
use prominent existing NP methods in a new task of inferring a dynamic rather than static condition-specific (aging-related)
network. Then, we study evolution of network structure with age – we identify proteins whose network positions significantly
change with age and predict them as new aging-related candidates. We validate the predictions via e.g., functional enrich-
ment analyses and literature search. Dynamic network inference via NP yields higher prediction quality than the only existing
method for inferring a dynamic aging-related BN, which does not use NP.
1 Introduction
1.1 Motivation and related work
Gene expression data, which have revolutionized our biomedical understanding1, capture valuable condition-specific informa-
tion (“condition” can mean a biological process, disease stage, age, patient, etc.). However, gene expression analyses ignore
connectivities between gene products (proteins) in the cell (we use terms “gene” and “protein” interchangeably). Yet, proteins
interact to carry out cellular functions, and this is what protein-protein interaction (PPI) networks model. So, PPI network
research can deepen our biomedical understanding2. However, the current PPI network of a species spans many conditions3.
Using the PPI data alone without looking at other condition-specific (typically gene expression) data fails to capture any
condition-specific knowledge.
Hence, recent studies integrated gene expression and PPI data via network propagation (NP), which maps gene activities
(expression levels) onto the corresponding proteins in the PPI network. Then, NP propagates the activities via random walks
or diffusion, to assign condition-specific weights to the nodes (proteins) or the edges (PPIs) in the network4,5, in order to
identify highly weighted network regions6–8. We note that there exists another category of data integration approaches, which
fuse condition-specific data with an individual biological pathway as opposed to the whole PPI network9–12. Since we are
interested in the latter, this approach category is out of the scope of our study. Also, besides NP methods, there exist other
non-NP types of methods that integrate condition-specific data with the whole PPI network, such as kernel, Bayesian, or
non-negative matrix factorization methods13,14. However, in our study, we focus on NP methods.
Existing NP approaches can be grouped into two categories. One category are approaches for condition-specific node
prioritization. These approaches use NP to assign weights to nodes in the network, with a hypothesis that the higher the
weight of a node, the more likely the node is to be related to the condition in question15,16. Approaches of this type typically
do not weigh edges.
The other category are approaches that focus on condition-specific subnetwork identification. These approaches use NP
to assign weights to edges (and sometimes also to nodes) in the network and then identify highly weighted network regions
as a condition-specific subnetwork. Here, condition-specific gene information can be gene expression data, or it can be gene
mutation data on e.g., how many patients have genes containing significantly associated single nucleotide polymorphisms,
indels, etc.
Two prominent methods from this category are NetWalk17 and HotNet218. NetWalk integrates the condition-specific gene
information with network topology immediately, by performing, from all nodes simultaneously, a randomwalk on the network
biased by the condition-specific gene information. On the other hand, HotNet2 first summarizes network topology in the form
of a diffusion matrix, by performing, from one node at a time, an unbiased random walk on the network; this matrix captures
the topological effect of each node on all other nodes in the network. Only then HotNet2 combines the condition-specific
gene information with the topology-based diffusion matrix. The new (final) diffusion matrix captures both the topological and
condition-specific effect of each node on all other nodes.
Also, NetWalk and HotNet2 differ as follows. As its output, NetWalk assigns weights to all edges in the network. The
edge-weighted network can then be used to identify a condition-specific subnetwork, by extracting only the highest-weighted
network regions. However, as a part of its algorithm, NetWalk does not explicitly define a procedure for doing this, and one
needs to devise it on their own. As its output, HotNet2 identifies a given group of nodes and all of their corresponding edges
from the entire PPI network as a condition-specific subnetwork if the nodes in the group have strong mutual effects according
to HotNet2’s final diffusion matrix.
Both methods have been used to study cancer, i.e., predict new cancer-related genes or molecular pathways17–20.
Other NP-based subnetwork identification methods exist. NetQTL21 and TieDIE22 hypothesize that for a given condition,
there is a set of source (e.g., transcription factor) genes that affect a set of target (e.g., differentially expressed) genes, and that
the important network paths connecting the source genes to the target genes are a good representation of the condition-specific
subnetwork. Hence, these methods propagate the condition-specific information from the source genes to the target genes, with
the goal of identifying important paths between the source and target genes. Clearly, unlike NetWalk and HotNet2, NetQTL
and TieDIE require two sets of condition-specific genes, i.e., sources and targets, in order to identify a condition-specific
subnetwork. As such, NetQTL and TieDIE are out of the scope of our study.
Another NP method exists that identifies each node’s “neighbor-network”, computes condition-specific activity of each
neighbor-network via its enrichment in highly expressed genes, and identifies all significantly active neighbor-networks as a
single condition-specific subnetwork23. We could not consider this approach, because its software has not been made available,
even after contacting the authors.
The existing NP studies obtained a single, static condition-specific PPI subnetwork. This is because they studied an n× 1
vector containing gene expression/mutation information of n genes for a single condition. Or, when they used an n×mmatrix
containing information of n genes for m conditions, they used all m conditions to compute a single activity value for the given
gene, thus summarizing the matrix into an n× 1 vector. For example,18 analyzed mutation weights of ∼12,000 (n) genes
across ∼3,000 (m) samples related to different cancer types, which they then summarized into an ∼12,000× 1 vector, where
a given position in the vector quantified the likelihood of the corresponding gene being active in many samples. Then, the
summarized vector was used to obtain a single (not necessarily connected) condition-specific subnetwork, i.e., subnetwork
active in several cancer types.
In contrast, cellular processes are dynamic. This includes human aging, which we are interested in studying because the
occurrence of serious diseases increases with age24–26. Hence, studying aging, a dynamic process, via inference and analysis
of a static aging-related network, can be limiting. We hypothesize that inferring and analyzing a dynamic aging-related
network is more promising when the goal is to study temporal changes of network structure and thus cellular functioning with
age.
Currently, there exists only one approach for inference of a dynamic aging-related network, which we refer to as induced
subgraph approach (ISA)27. Given gene expression data for multiple ages and a static PPI network, ISA identifies, for a
given age, all proteins that are active (significantly expressed) at that age and all PPIs involving these proteins (i.e., it extracts
the induced subgraph among the active proteins). This results in a PPI subnetwork that is specific to the age in question.
Repeating this for all ages results in one age-specific PPI subnetwork per age, which combined form a dynamic aging-related
PPI network. In addition to Faisal et al.27, other studies used ISA as well to construct dynamic condition-specific PPI networks
relevant for studying prion disease or metabolic cycles (rather than aging)28–30. Methodologically, these studies differ from
the Faisal et al.27 study mainly in how they defined a gene to be active at a given time point.
Note that this type of a dynamic network that is constructed by integrating static PPI network with temporal gene expres-
sion data should not be confused with the concept of dynamic network biomarkers. This is because the latter deals only with
temporal gene expression data; it uses no PPI data. Namely, the goal is to identify a group of genes whose expressions corre-
late over time better compared to the genes outside the group. The identified group of genes are then considered as biomarkers
for the condition of interest31–33. As such, this concept is out of the scope of our study.
ISA considers all interactions from the static network that exist between only active genes. However, first, not all interac-
tions between the active proteins might be equally “important”. ISA has no mechanism of identifying only the most important
(e.g., highly weighted) of all interactions between the active genes. NP methods for subnetwork identification, which are
able to assign condition-specific weights to edges, can help. Second, it might be important to consider both active proteins
and non-active proteins that critically connect the active proteins in the network, which ISA fails to do. NP can help, be-
cause it propagates activities of highly expressed nodes to other nodes in the network, thus possibly giving a high weight to a
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Figure 1. Summary of our study. We integrate a static human PPI network with gene expression data at different ages, using
five versions of three approaches, which results in five dynamic aging-related PPI networks. For each dynamic network, we
study changes in global and local network topology with age. While global network topology does not change with age, we
find significant changes in local network neighborhoods of 156-1,519 proteins, depending on the dynamic network. We
predict such proteins as aging-related candidates. For the five dynamic networks, this results in five aging-related gene
prediction sets. We validate the prediction sets in several ways, as shown in the figure. For details on each step of our study,
see Section 2.
non-active node if e.g., it is surrounded by many active nodes or is on many paths between active nodes.
To address these drawbacks of ISA, we generalize the existing NP methods for static condition-specific subnetwork iden-
tification to their dynamic counterparts. We hypothesize that using NP rather than ISA will improve the quality of the inferred
dynamic aging-related PPI network and thus yield higher-quality aging-related gene predictions. Note that we do not con-
sider NP methods for node prioritization, because they have a different goal than our goal of condition-specific subnetwork
identification.
1.2 Our study and contributions
We test our hypothesis using NetWalk and HotNet2 NP methods. While one might argue that other NP methods for sub-
network identification exist that could perhaps be used instead, showing that at least one of these two considered methods
improves upon ISA is sufficient to confirm our hypothesis. Using any other potentially superior NP method would only fur-
ther strengthen the superiority of NP over ISA. We use each of NetWalk, HotNet2, and ISA to integrate aging-related gene
expression data with static human PPI network data, in order to construct a dynamic aging-related network corresponding to
the given approach (Fig. 1).
After we study (dis)similarities between the dynamic networks of the different approaches, we analyze which one is of the
highest quality, i.e., the most relevant for the aging process. For this, we use an established framework for dynamic network
analysis of aging that studies how network positions (centralities) of proteins change with age and predicts the significantly-
changing proteins as aging-related candidates27. We apply the framework to the dynamic networks of the different approaches,
resulting in a set of aging-related gene predictions for each approach. We validate, i.e., quantify the quality of, the predicted
gene sets by measuring their overlaps with independent aging-related “ground truth” data and via functional or disease enrich-
ment analyses.
We find that our NP-based predicted gene sets have significant gene, functional, or disease overlaps with the “ground truth”
data. Importantly, the overlaps are better for our NP-based predicted gene sets than for the gene set predicted by ISA. For
example, for GenAge, a trustworthy aging-related “ground truth” data34, one of the NP approaches shows significantly high
gene overlap of ∼25% (p-value of 4.7× 10−5), compared to ISA’s overlap of ∼8% (p-value of 0.15). As another example,
genes predicted by ISA are not enriched in any aging-related Gene Ontology (GO) terms35,36, while the NP-based predicted
genes are.
All of the predicted gene sets, including ISA’s, contain novel genes, i.e., genes that are not present in any of the “ground
truth” data. Since NP-based predicted gene sets show higher overlaps with the “ground truth” data, we trust their novel genes
more than ISA’s novel genes. Also, for each approach, we find predictions that are unique to it, implying that the different
approaches, i.e., different dynamic networks, are capturing at least somewhat complementary aging-related information. This
is not surprising, given that the networks show pairwise node overlaps that are as low as ∼50% and pairwise edge overlaps
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that are as low as ∼30%.
We perform literature validation with the goal of linking to aging the novel NP-based predicted genes that cannot be
predicted by ISA. We successfully validate 20 out of 22 (i.e., 91% of) such predictions.
2 Methods
2.1 Data and their integration
2.1.1 Static human PPI network data
We use the human PPI network from HPRD37, the same data used in the dynamic network study of aging that proposed ISA27.
We extract the network’s largest connected component, which has 8,938 nodes and 35,900 edges. We denote this network as
hprdPPI and its set of nodes as StatNetGenes. We focus on the HPRD PPI data rather than alternative PPI data because we
aim to mimic the ISA study in all aspects except how the input static PPI network and aging-related gene expression data are
integrated; that is, we aim to use NP rather than ISA for data integration. The ISA study focused in depth on the HPRD PPI
data, which is why we use the same data here as well. Also, the ISA study briefly analyzed the BioGRID PPI data and found
the results to be qualitatively similar, i.e., the choice of PPI data did not have a major effect27.
2.1.2 Aging-related gene expression data
We use the same human brain aging-related gene expression data that was used in the ISA study27. The data encompasses 173
samples (with an average of five samples per age) from 55 different individuals that span 37 different ages between 20 and
99 years. In order to identify whether a gene is significantly expressed (i.e., active) at a given age, we follow the procedure
from the ISA study (Supplementary Section S1). Note that this study accounted for qualitative information (whether a gene
is active at a given age or not), but not for quantitative information about the actual gene expression values. The NP methods
require as input the quantitative information, i.e., assigning scores to genes (Section 2.1.3). So, as gene scores, we use the
gene expression values: an age-specific score for a gene is the average of the gene’s log-scaled expression values across all
samples for the given age. For details, see Supplementary Section S1.
We focus on this gene expression data by Berchold et al.38 rather than alternative data because we aim to mimic the ISA
study in all aspects except how we integrate the input data. The ISA study focused in depth on this data, which is why we
use it here as well. Also, the ISA study also briefly analyzed an alternative gene expression data39 and found the results to be
qualitatively similar, i.e., the choice of aging-related gene expression data did not have a major effect.
2.1.3 Integrating gene expression data with static PPI network to obtain dynamic aging-related PPI networks
We use three methods to construct dynamic aging-related PPI networks: ISA, HotNet2, and NetWalk. For each of the latter
two, we use two versions: one that uses expression values of only active genes (HotNet2 and NetWalk), and another one that
uses expression values of all genes (HotNet2* and NetWalk*); for our definition of an active gene, see Section 2.1.2. Thus,
we analyze five versions of the three methods. Due to space constraints, details about how each method version works are
given in Supplementary Section S2. Given a method version, we do the following. To create a PPI subnetwork specific to
a given age, we map the genes that are active at that age onto the static PPI network and apply the underlying method. We
do this for all 37 ages and obtain 37 age-specific PPI subnetworks, which comprise a dynamic PPI network. In this way,
we obtain a single (best-case) dynamic aging-related network for each of HotNet2, HoNet2*, NetWalk, NetWalk*, and ISA
(Supplementary Sections S2 and S3). We denote the corresponding dynamic networks as HnNet, HnNet*, NwNet, NwNet*,
and iNet, respectively.
2.1.4 Aging-related “ground truth” data
By studying brain gene expression data with 174 samples from 55 individuals, with multiple sample per individual, Berchold
et al.38 identified 8,277 genes (via 12,514 probes) whose expression significantly changed with age. Of these, 4,274 are
present in StatNetGenes. We denote this aging-related “ground truth” set of 4,274 genes as BEx2008.
By studying brain gene expression data, Lu et al.40 predicted 442 genes as aging-related, since their expressions signifi-
cantly correlated with age. Of these, 335 genes are present in StatNetGenes. We denote this aging-related “ground truth” set
of 335 genes as BEx2004.
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By studying brain gene expression dataset related to different stages of Alzheimer’s disease (AD), Simpsom et al.41 iden-
tified 2,911 genes that have significantly different expression levels at different stages of AD. Of these, 1,475 are present in
StatNetGenes. We denote this AD-related “ground truth” set of 1,475 genes as ADEx2011.
GenAge version used in the ISA study27 contained 261 human genes linked to aging mostly as sequence-based orthologs
of aging-related genes in model species34. Of these, 239 are present in StatNetGenes. We denote this sequence-based aging-
related “ground truth” set of 239 genes data as SeqAge.
Of all GO terms, we identify as aging-related those that contain “age” or “aging” in their names. This results in six such
GO terms that annotate at least two proteins from StatNetGenes (Supplementary Table S1).
2.2 (Dis)similarities between different dynamic networks
We evaluate (dis)similarities between the aging-related dynamic networks (HnNet, HnNet*, NwNet, NwNet*, and iNet) by:
(1) measuring their pairwise node and edge overlaps, (2) comparing them to each other with respect to three global network
properties ( average clustering coefficients, average diameters, and graphlet frequency distribution), to see if the networks
have (dis)similar topologies, and (3) evaluating their fit to five graph families or network models (Erdos-Renyi random graphs
(ER), generalized ER with same degree distribution as the data network (ER-DD), geometric random graphs (GEO), scale-free
network model (SF), and sticky graph model (Sticky)), to see if they belong to (dis)similar graph families. For details, see
Supplementary Section S4.
2.3 Do global properties of networks change with age?
For each dynamic network, we evaluate whether its global topology changes with age. Namely, we: (1) measure pairwise
node and edge overlaps of its age-specific subnetworks, (2) compare its age-specific subnetworks with respect to the three
global network properties, and (3) evaluate the fit of the age-specific subnetworks to the five network models. For details, see
Supplementary Section S4.
2.4 Do local properties of proteins change with age?
For each dynamic network, we study topological positions (centralities) of nodes in each of its 37 age-specific subnetworks
using six measures: degree centrality (Degc), clustering coefficient centrality (Clusc), k-coreness centrality (Kc), graphlet
degree centrality (Gdc), closeness centrality (Closec), and eccentricity centrality (Ecc)27.
2.4.1 Prediction of aging-related genes
Here, we rely on an established computational framework for dynamic network study of aging, which was proposed at the
same time as ISA27. For each dynamic network, the framework computes, for every centrality measure, the centrality value of
each node in each of the 37 age-specific PPI subnetworks. Then, it computes the Pearson correlation between the given node’s
centrality values and the 37 ages and the statistical significance of this correlation, where the p-value is the percentage of
1,000,000 random runs in which the random correlation is better than the actual correlation, which is then adjusted to account
for multiple test correction. The framework predicts a gene as aging-related if for at least one centrality measure, the gene’s
adjusted p-value is < 0.01.
2.4.2 Validation of predicted aging-related genes
Overlap between two gene sets. We measure the significance of the overlap of any two subsets of StatNetGenes using the
hypergeometric test. If S is StatNetGenes, A is one of the two datasets, B is the other dataset, and O is the overlap between A
and B, then the p-value is:
P(X ≥ |O|) = 1−
|O|−1
∑
i=0
(
|S|
i
)(|S|−|A|
|B|−i
)
(|S|
|B|
) (1)
We say that the overlap is significant if its p-value is ≤ 0.01.
GO enrichment. We study enrichment of a gene set in GO terms. We use 9,464 GO terms that annotate at least two genes in
StatNetGenes. For a GO term g, we compute the significance of its enrichment using equation 1. Now, S is the subset of genes
from StatNetGenes where each gene is annotated by at least one GO term, A is the set of genes whose GO term enrichment
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we are measuring, B is the subset of genes from S that are annotated by GO term g, and O is the overlap of sets A and B. We
say that a GO term is enriched in a gene set if the enrichment p-value is ≤ 0.01.
GO term overlap. We measure the significance of the overlap of enriched GO terms between two datasets using equation 1.
Now, S is the set of GO terms that annotate at least one gene from StatNetGenes, A is the set of GO terms enriched in one of
the datasets, B is the set of GO terms enriched in the other dataset, and O is the overlap between A and B. We say that the
overlap is significant if its p-value is ≤ 0.01.
DO enrichment. We study enrichment of a dataset in DO terms, in the same way as we study GO enrichment (see above).
We use 991 DO terms that annotate at least two genes in StatNetGenes42.
DO term overlap. We measure the significance of the overlap of enriched DO terms between two datasets, just as we do GO
term overlap (see above).
Literature validation. We search for a gene in PubMed (https://pubmed.gov) or Google Scholar (https://scholar.google.com)
to link it to aging by closely reading the relevant research articles.
3 Results and discussion
We integrate aging-related gene expression data with static human PPI network data using five approaches (HotNet2, Hot-
Net2*, NetWalk, NetWalk*, and ISA; Section 2.1) to obtain five aging-related dynamic networks (HnNet, HnNet*, NwNet,
NwNet*, and iNet; Section 2.1.3). In section 3.1, we study and compare global network topology of the dynamic aging-related
networks (Section 2.2). In Section 3.2, for each dynamic network, we study changes in its global network topology with age
(Section 2.2). In Section 3.3.1, for each dynamic network, we study changes in local topology of its proteins with age, and
predict the significantly-changing nodes as aging-related (Section 2.4). In Section 3.3.2, we compare the predictions produced
by the different dynamic networks, i.e., different approaches, to validate that the NP-based predictions have higher quality
than ISA’s predictions (Section 2.4).
3.1 Dynamic networks contain different nodes and edges but show similar global topology
Since we use the different data integration methods to create the dynamic aging-related networks, we would not be surprised
if the networks are (somewhat) dissimilar. We expect differences between iNet and any of the other NP-based dynamic
networks, because of the different algorithmic mechanisms behind the underlying data integration approaches. Also, we
expect differences between HnNet and HnNet*, as well as between NwNet and NwNet*, because of how the underlying
methods account for age-specific genes scores (Section 2.1.3). At the same time, because HnNet and HnNet*, as well as
NwNet and NwNet*, share the underlying NP algorithm, we expect larger similarities between these networks too.
Our findings in terms of sizes of the five dynamic networks are shown in Fig. 2 (left) and Supplementary Fig. S1.
Regarding the number of nodes, we find two groups of networks that are similar: three of the networks, HnNet, NwNet*, and
iNet, all have ∼4,500 nodes, while the other two networks, HnNet* and NwNet, both have∼7,000 nodes. Thus, surprisingly,
iNet is more size-similar to some of the NP-based networks than the NP-based networks are to each other. Also, surprisingly,
HnNet is more similar to NwNet* than it is to HnNet*, and NwNet is more similar to HnNet* than it is to NwNet*, even
though the more similar networks do not share the underlying NP algorithm. Regarding the number of edges, i.e., density, all
networks except HnNet and iNet have different densities.
We measure node/edge overlaps between the dynamic networks (Supplementary Figs. S2 and S3). First, we focus on over-
laps between iNet and the other NP-based dynamic networks, to understand whether NP adds/removes nodes/edges to/from
the dynamic network compared to ISA. High node/edge overlap between iNet and an NP dynamic network would mean
that the NP network does not add many new nodes/edges to iNet nor removes many existing nodes/edges from iNet. A low
node/edge overlap of iNet with an NP dynamic network would mean that either the NP network adds many new nodes/edges
to iNet, or it removes many existing nodes/edges from iNet, or both. Our findings are as follows.
In terms of node overlaps, iNet has high (∼94%) overlap with HnNet but relatively low (∼50%-∼71%) overlaps with
NwNet, NwNet*, and HnNet* (Fig. 2 (right)). Of the latter three, NwNet only adds new nodes to iNet, while NwNet* and
HnNet* both add new nodes to iNet and also remove existing nodes from iNet (Supplementary Table S2).
In terms of edge overlaps, iNet has high (∼94%) overlap with HnNet but relatively low (∼36%-∼62%) overlaps with
NwNet, NwNet*, and HnNet* (Supplementary Fig. S3). Of the latter three, NwNet only adds new edges to iNet, while
NwNet* and HnNet* both add new edges to iNet and also remove existing edges from iNet (Supplementary Table S3).
Second, we focus on overlaps between the NP-based dynamic networks (Supplementary Fig. S3). Node overlaps range
from∼52% to ∼72% (Fig. 2 (right)). Surprisingly, HnNet shows higher overlap with NwNet* than with HnNet*, and NwNet
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Figure 2. Comparison of the five dynamic networks in terms of node size and density (left) and node overlaps (right). In the
left panel, each point is the average over the 37 ages, and the vertical and horizontal lines (if visible) represent the
corresponding standard deviations. In the right panel, each table cell shows the average node overlap over the 37 ages. For
pairwise edge overlaps, see Supplementary Fig. S3.
shows higher overlap with HnNet* than with NwNet*, even though the networks showing higher overlaps do not share the
underlying NP algorithm. The results for edge overlaps are similar.
When we compare global properties of the dynamic networks, we find that their average clustering coefficients, average
diameter, and graphlet frequency distributions are similar (Supplementary Figs. S4 and S5). The best fitting network models
are the same for all of the dynamic networks. Namely, both Sticky and GEOmodels are the best-fitting models for all dynamic
networks, except for NwNet where Sticky is the best, and for HnNet* where GEO is the best (Supplementary Fig. S6).
3.2 Global network properties do not change with age
For each of the dynamic networks, we observe the following. First, pairwise node and edge overlaps of the age-specific subnet-
works are large (most are 80% or larger; Supplementary Figs. S7 and S8). Second, the average clustering coefficients, average
diameters, and graphlet frequency distributions of the age-specific subnetworks are overall stable with age (Supplementary
Figs. S4 and S5). Third, the age-specific subnetworks belong to the same network model (Supplementary Fig. S6).
3.3 Local topology of proteins change with age
3.3.1 Prediction of aging-related genes.
Mimicking the ISA study27, for each of the five dynamic networks (NwNet, NwNet*, HnNet, HnNet*, and iNet), we use node
centrality measures to study how local topology of proteins change with age, and to predict proteins whose node centralities
significantly correlate with age as aging-related (Section 2.4).
We denote the resulting five predicted aging-related gene sets as NwNetAge, NwNetAge*, HnNetAge, HnNetAge*, and
iNetAge, respectively. The number of predicted genes varies from ∼2% (HnNetAge*) to ∼17% (NwNetAge*) of all 8,938
proteins in the PPI network (Table 1 and Supplementary Figs. S9 and S10).
Since we use the same input data to obtain all five predicted gene sets, we expect a significant overlap between them.
Indeed, we find that the overlaps are significant for all pairs of gene sets, except for any pair that includes HnNetAge* (Table
1). This could be due to its dynamic network, HnNet*, having considerably lower node and edge overlaps with the other
dynamic networks than the other networks have with each other (Supplementary Fig. S3). It is expected that the more
dissimilar the network, the more dissimilar the predictions made from the network.
Since we find significant overlaps between most of the predicted gene sets, we expect some genes to be present in multiple
prediction sets. Indeed, we find a number of such genes: when considering all 2,196 genes predicted by any of the five
approaches, 1,624 (74%), 318 (14.5%), 200 (9.1%), 51 (2.3%), and 3 (0.1%) of them are predicted by exactly one, two,
three, four, and five approaches, respectively (Supplementary Fig. S11). For equivalent results when considering only those
predicted genes that are absent from the aging-related “ground truth” datasets, or those predicted by the four NP approaches
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Table 1. Pairwise gene overlaps between the predicted gene sets. For the given set, its size is in parentheses. In each table
cell, we show (from the top): 1) the number of genes in the overlap, 2) overlap size as the percentage of the union of the two
sets, 3) overlap size as the percentage of the smaller of the two sets, and 4) the p-value of the overlap. The significant
p-values are bolded.
NwNetAge
(417)
NwNetAge*
(1519)
HnNetAge
(437)
HnNetAge*
(156)
iNetAge
(550)
NwNetAge
(417)
417
100%
100%
¡1.0e-300
125
6.9%
30%
1.4e-11
151
21.5%
36.2%
1.3e-97
9
1.6%
5.77%
0.305
168
21%
40.3%
4.8e-100
NwNetAge*
(1519)
125
6.9%
30%
1.4e-11
1519
100%
100%
¡1.0e-300
153
8.49%
35%
6.7e-21
31
1.89%
19.9%
0.194
192
10.2%
34.9%
5.3e-26
HnNetAge
(437)
151
21.5%
36.2%
1.3e-97
153
8.49%
35%
6.7e-21
437
100%
100%
¡1.0e-300
7
1.19%
4.49%
0.646
411
71.4%
94.1%
¡1.0e-300
HnNetAge*
(156)
9
1.6%
5.77%
0.305
31
1.89%
19.9%
0.194
7
1.19%
4.49%
0.646
156
100%
100%
¡1.0e-300
7
1%
4.49%
0.853
iNetAge
(550)
168
21%
40.3%
4.8e-100
192
10.2%
34.9%
5.3e-26
411
71.4%
94.1%
¡1.0e-300
7
1%
4.49%
0.853
550
100%
100%
¡1.0e-300
but not ISA, which are qualitatively similar, see Supplementary Fig. S12. Genes present in multiple prediction sets may be
more likely to be aging-related than those present in one set.
Additionally, we find a number of genes that are exclusively (uniquely) present only in a given predicted gene set but not
in others, indicating that the different predicted gene sets are capturing at least some complementary aging-related information
(Supplementary Figs. S13 and S14). While one might argue that these unique genes could be the result of statistical bias, for
each of the prediction sets, a majority of the unique genes are present in the “ground truth” data (Supplementary Figs. S13
and S14), which increases our confidence in them.
3.3.2 Validation of predicted aging-related genes
Gene overlaps between the predicted gene sets and aging-related “ground truth” data are significant, and overlaps of
the NP-based predictions are more significant than those of ISA. Recall that we use four “ground truth” aging-related
datasets: BEx2008, BEx2004, ADEx2011, and SeqAge (Section 2.1.4). Since BEx2008 is based on the same gene expression
data that we use in our study to produce the predictions, we expect significant gene overlaps between the five predicted gene
sets and BEx2008. Since BEx2004 is based on the same data type as BEx2008 – brain aging-related expression data – but
not directly on the same data that we use, we might or might not see a significant overlap with BEx2004. A high overlap of
BEx2004 would be encouraging. A significant overlap with ADEx2011 would be even more encouraging. This is because
ADEx2011 contains an expression-based list of Alzheimer’s disease-related genes and is thus still somewhat related to our
input data (as both are expression-based and brain-related), although ADEx2011 is less similar to our input data than BEx2008
and BEx2004 are, because our data is not directly related to Alzheimer’s disease. Lastly, a significant overlap with SeqAge
would be the most encouraging, because SeqAge (i.e., GenAge) is considered to be the most trustworthy source of human
aging-related knowledge, and because SeqAge, being sequence-based, is the least similar to our input data, as the latter are
not sequence-based.
When we compute gene overlaps between each of the five predicted gene sets and each of the four “ground truth” datasets,
we observe that, in general, the predicted gene sets show significant overlaps with the “ground truth” datasets (Table 2 and
Supplementary Figs. S15-S18).
Specifically, from a “ground truth” dataset-focused angle, as expected, BEx2008 significantly overlaps with all predicted
gene sets, except with HnNetAge*. Somewhat surprisingly, BEx2004 significantly overlaps with only one of the predicted
gene sets, while each of ADEx2011 and SeqAge overlaps with three of the five predicted sets.
From a prediction set-focused angle, NwNetAge* overlaps with all four “ground truth” datasets, NwNetAge, HnNetAge
and iNetAge overlap with two of the four “ground truth” datasets, and HnNetAge* overlaps with one of the four “ground truth”
datasets. Hence, at least one of the NP-based prediction sets (NwNetAge*) overlaps with more of the “ground truth” datasets
than ISA’s prediction set (iNetAge), and actually the former overlaps with all considered “ground truth” datasets, unlike the
latter. So, this is the first evidence that NP improves upon ISA.
8/13
Table 2. Gene overlaps between the predicted gene sets (columns) and the aging-related “ground truth” datasets (rows). The
numbers in the table can be interpreted just as those in Table 1. The table cells with significant p-values that improve upon
iNetAge are highlighted in gray.
NwNetAge
(417)
NwNetAge*
(1519)
HnNetAge
(437)
HnNetAge*
(156)
iNetAge
(550)
BEx2008
(4274)
259
5.8%
62%
1.4e-9
1029
22%
68%
3.2e-66
324
7.4%
74%
1.6e-30
76
1.7%
49%
0.442
404
9.1%
73%
1.7e-36
BEx2004
(335)
23
3.2%
6.9%
0.04
89
5%
27%
4.7e-6
22
2.9%
6.6%
0.097
4
0.82%
2.6%
0.842
29
3.4%
8.7%
0.039
ADEx2011
(1475)
82
4.5%
20%
0.046
339
13%
23%
5.4e-11
103
5.7%
24%
6.0e-5
19
1.2%
12%
0.947
121
6.4%
22%
3.2e-4
SeqAge
(239)
39
6.3%
16%
4.4e-12
61
3.6%
26%
4.7e-4
13
2%
5.4%
0.387
11
2.9%
7.1%
0.003
19
2.5%
7.9%
0.15
An additional evidence is that not only does NwNetAge* (and two other NP-based prediction sets) significantly overlap
with SeqAge, while iNetAge does not, but even for the “ground truth” datasets that iNetAge does significantly overlap with,
NwNetAge* overlaps with those datasets even better (more significantly, as captured by lower p-values in Table 2).
GO term enrichment. We find that each of the predicted gene sets is significantly enriched in a number of GO terms,
between 107 and 267 of them, depending on the prediction set. Importantly, while iNetAge is not enriched in any of the six
aging-related GO terms (Section 2.1.4), three of the four NP-based predicted gene sets are enriched in one or two of such
GO terms (Table 3). This is an additional evidence that the NP-based predictions are more relevant for the aging process than
ISA’s predictions.
Table 3. A list of the aging-related GO terms that are enriched in at least one predicted gene set. In the given row, the
number in parentheses indicates the number of genes in the corresponding prediction set that are annotated by at least one
GO term. In the given column, the number in parentheses indicates the number of genes in StatNetGenes that are annotated
by the corresponding aging-related GO term. In each table cell, we show (from the top): 1) the number of genes in the
overlap of the two sets and 2) the p-value of the overlap. The significant p-values are bolded. The table cells with significant
p-values that improve upon iNetAge are highlighted in gray.
GO:0007568 (Ag-
ing)
(147)
GO:0007569 (Cell aging)
(23)
NwNetAge
(404)
17
4.9e-4
6
5.2e-4
NwNetAge*
(1478)
37
0.008
5
0.356
HnNetAge
(434)
6
0.755
4
0.026
HnNetAge*
(154)
8
0.005
0
NA
iNetAge
(540)
7
0.821
4
0.052
GO term overlap. When we measure the overlap of GO terms that are enriched in a given predicted gene set and GO terms
that are enriched in a given “ground truth” dataset, we find that iNetAge significantly overlaps with BEx2008, BEx2004, and
SeqAge but not with ADEx2011 (Table 4). Three of the four NP-based prediction sets (all but HnNetAge*) also significantly
overlap with BEx2008, and one of them overlaps with BEx2008 better (more significantly, as captured by the lower p-value)
than iNetAge. Similarly, all four of the NP-based prediction sets also show significant overlap with BEx2004, and three of
them (NwNetAge, NwNetAge*, and HnNetAge) overlap with BEx2004 better than iNetAge. Furthermore, two of the four
NP-based prediction sets (NwNetAge* and HnNetAge) significantly overlap with ADEx2011, unlike iNetAge. Finally, all
four NP-based prediction sets also show significant overlap with SeqAge, and three of them (NwNetAge, NwNetAge*, and
HnNetAge*) have overlap with SeqAge better than iNetAge.
Importantly, one of the NP-based prediction sets (NwNetAge*) significantly overlaps with all four “ground truth” datasets,
unlike iNetAge. This further demonstrates that using NP to create dynamic networks and produce aging-related gene predic-
tions improves upon using ISA to do so.
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Table 4. GO term overlaps between the predicted gene sets the aging-related “ground truth” datasets. The table can be
interpreted just as Table 2.
NwNetAge
(257)
NwNetAge*
(267)
HnNetAge
(166)
HnNetAge*
(107)
iNetAge
(169)
BEx2008
(247)
30
6.3%
12%
3.9e-12
89
21%
36%
3.7e-78
30
7.8%
18%
2.3e-17
6
1.7%
5.6%
0.061
38
10%
22%
2.0e-25
BEx2004
(221)
24
5.3%
11%
6.2e-9
32
7%
14%
1.4e-14
20
5.4%
12%
1.5e-9
12
3.8%
11%
6.9e-6
19
5.1%
11%
1.3e-8
ADEx2011
(117)
14
3.9%
12%
3.2e-6
30
8.5%
26%
5.2e-21
6
2.2%
5.1%
0.017
1
0.45%
0.93%
0.738
4
1.4%
3.4%
0.157
SeqAge
(913)
117
11%
46%
2.1e-52
66
5.9%
25%
2.8e-13
43
4.2%
26%
9.1e-10
40
4.1%
37%
7.8e-15
44
4.2%
26%
4.8e-10
DO term enrichment. We find that the predicted gene sets are significantly enriched in 2-29 DO terms, depending on the
set. It is encouraging that, unlike iNetAge, one of the NP-based predicted gene sets (NwNetAge) is enriched in Parkinson’s
disease (DOID:14330) and Tauopathy (DOID:680), both of which have been linked to human aging43–45.
DO term overlap. When we measure the DO term overlap between a given predicted gene set and a given “ground truth”
dataset, in general, we find very little overlap (Supplementary Table S4). This could be because most of the predicted as well
as “ground truth” sets are enriched in very few DO terms. Yet, while iNetAge shows no (significant or non-significant) overlap
with any “ground truth” dataset, one of the NP-based prediction sets (NwNetAge*) shows two non-significant overlaps (with
BEx2004 and SeqAge), and another one (NwNetAge) shows two non-significant overlaps (with BEx2004 and ADEx2011)
and importantly one significant overlap (with SeqAge). Regarding the latter, of the 29 DO terms enriched in NwNetAge,
17 (59%) are also enriched in SeqAge (p-value of 3.5× 10−6). This result further increases the credibility of the NP-based
predictions and strengthens the superiority of NP over ISA.
3.4 Literature validation of novel predictions
We identify all genes that are present in at least two of the four NP-based predicted gene sets and are not present in any of the
aging-related “ground truth” data or in iNetAge. There are 22 such genes (Supplementary Fig. S19). We successfully validate
20 of them in the literature (Table 5).
4 Conclusion
Our results imply that integration of aging-related gene expression data with static PPI network data via NP improves the
quality of aging-related gene predictions made from the data compared to the only existing approach for this purpose, ISA. In
the process of our comprehensive evaluation of the compared approaches, we also predict novel human aging-related genes
and validate 91% of them in the literature.
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